Minimizing Luck in Study Feasibility

whitePaper | December 9, 2022

There’s no such thing as a “one size fits all” patient engagement strategy. Healthcare organization executives should beware— using conventional scoring tools to predict how patients will engage with and pay their healthcare bills is not an effective strategy.

whitePaper | June 24, 2023

A first-in-human (FIH) clinical trial is a significant milestone in the development of a potential new drug in that it will be the first opportunity for a drug development sponsor to evaluate the impact of their new chemical entity (NCE) or biologic in humans.

whitePaper | January 14, 2022

In the past year, more than nine billion doses of coronavirus vaccines have been administered, in at least 197 countries worldwide according to the BBC and Oxford University.

whitePaper | January 14, 2023

After being hit the hardest by the pandemic, many emerging market stakeholders are now looking for impactful, long-term partnerships with global healthcare companies that add real value to local populations.

whitePaper | January 17, 2020

Value-based reimbursement (VBR) models are becoming more common. Success under these models depends on showing positive improvement in key metrics, but providers often struggle to accurately report the quality of care provided. A next-generation revenue cycle that combines clinically aware artificial intelligence (AI) with an unmatched foundation of evidence-based medical research and knowledge provides the transparency necessary to both accurately report care quality and directly influence the patient satisfaction quality metric. This paper reviews how a well-tuned revenue cycle can help hospitals succeed with value-based contracts, earning appropriate incentives and avoiding penalties.

whitePaper | December 15, 2022

Every segment in health care is experiencing extraordinary changes in the workforce. Burnout, turnover, rising labor costs and skill gaps are diminishing the supply of qualified workers.